Table 1.
Organotropic site | Target | Role | Mechanism | Authors |
---|---|---|---|---|
Liver metastasis | GDH | Promotes | STAT3-mediated EMT induction | Liu et al. [43] |
GLS1 | Promotes | HIF-1 promotes GLS1 expression | Xiang et al. [44] | |
TPO | Promotes | TPO enhances hepatic metastasis of CD110 + TICs by activating lysine degradation | Wu et al. [45] | |
FOXP3 | Promotes | Potential to play a role in cancer progression and metastasis | Wang et al. [46] | |
PDK1 | Promotes | PDK1 knockdown increased reactive oxygen species | Qin et al. [47] | |
ALDOB | Promotes | Metastatic cells in the liver upregulate the ALDOB, which enhances fructose metabolism | Bu et al. [48] | |
PGI | Promotes | Overexpression of PGI contributes to the aggressive phenotype of human colon cancer | Tsutsumi et al. [49] | |
SIRT2 | Promotes | Liver metastasis involves IDH1 K224 hyperacetylation by inhibiting SIRT2 through HIF-1α-dependent SRC transcription, promoting invasion and migration | Wang et al. [50] | |
PEPCK | Promotes | PCK1 enhances pyrimidine nucleotide production, which facilitates cancer cell Development in the context of hypoxia | Yamaguchi et al. [51] | |
PKLR | Promotes | PKLR promotes cell survival in the tumor core in high cell density and hypoxia | Nguyen et al. [52] | |
CKB | Promotes | By downregulating miR-483 and miR-551a, CKB release into the microenvironment is stimulated, promoting liver colonies | Loo et al. [53] | |
GATM | Promotes | Elevated intratumoral creatine levels or GATM-mediated synthesis can enhance Slug and Snail expression via MPS1-activated Smad2/3, promoting liver metastasis | Zhang et al. [54] | |
CXCR4 | Promotes | Exosomes may promote colorectal cancer metastasis by recruiting CXCR4-expressing stromal cells to form a permissive metastatic microenvironment | Wang et al. [71] | |
Exosomal HSPC111 | Promotes | Mediated pre-metastatic niche formation | Zhang et al. [72] | |
ITGαvβ5 | Promotes | ITGαvβ5 preferentially adhered to Kupffer cells, enhancing hepatic tropism | Hoshino et al. [70] | |
Exosomal miR-221/222 |
Promotes | Activates hepatic hepatocyte growth factor (HGF) in CRC exosome | Tian et al. [75] | |
Exosomal miR-21-5p |
Promotes | Caused a pro-inflammatory phenotype and liver metastasis of cancer via the miR-21-Toll-like receptor 7-IL-6 axis | Shao et al. [76] | |
Fn-derived miR-1246,92b-3p,27a-3p | Promotes | Facilitate the liver metastasis of uninfected cells | Guo et al. [77] | |
miR-139-3p miR-193a let-7 g |
Promotes | Plasma exosomal was used to monitor CRC metastasis in real-time | Liu-cho et al. [78, 79] | |
miR-253p,130b-3p,425-5p, 193a |
Promotes | Potential to play a role in cancer progression and metastasis | Liu, Wanget al. [80, 81] | |
Exosomal miR-934 | Promotes | Enhanced M2 macrophage polarization in CRC cells by downregulating PTEN levels and activating the PI3K/AKT pathway | Li et al. [82] | |
Exosomal miR-1246 | Promotes | Mutant p53 CRC can transduce macrophages into M2-like macrophages with the help of exosomal miR-1246 | Cooks et al. [113] | |
HGF/cMet, PRL3, L1CAM, CXCR4, CAFs, Trop-2, ZFP57 | Promotes | Those key candidate genes associated with colon cancer liver metastasis | Trusolino ~ Shoji et al. [148–160] | |
Lung metastasis | ACLY | Promotes | Increased expression of ACLY may enhance cell lipid production and lung metastasis | Wen et al. [56] |
SCD1 | Promotes | Hyperglycemia-SCD1-MUFA caused CRC cell migration and invasion via PTEN regulation | Ran et al. [57] | |
Glut3 | Promotes | Stimulation of the Glut3-YAP signaling pathway acts as a master activator to change the cancer metabolism | Kuo et al. [58] | |
BCKDK | Promotes | Phosphorylated BCKDK at the tyrosine 246 (Y246) site, enhancing CRC cell invasion | Tian et al. [59] | |
HOXA13 | Promotes | Expedited CRC lung metastasis via performing | Qiao et al. [60] | |
Exosomes (MiR-25-3p MiR-106b-3p ITGBL1) |
Promotes | CRC cells induce premetastatic niche formation by secreting exosomes to promote CRC lung metastasis | Song, Wang, Ji et al. [42, 83, 84] | |
TAM secreting (TGF-β) |
Promotes | Induces EMT by activating the Smad2/3/4 Snail pathway | Shen et al. [85] | |
KRAS mutation | Promotes | Predisposition to lung metastasis | Kim,Tie,Cho et al. [161–163] | |
REG1B, TGM6, NTF4, PNMA5, and HOXC13 | Promotes | Those key candidate genes associated with colon cancer lung metastasis | Zhou et al. [164] | |
Peritoneal metastasis | CD44 | Promotes | CD44-enriched vesicles induce the secretion of matrix metalloproteinases (MMPs), compromising mesothelial barrier integrity and facilitating cancer cell invasion | Nakamura et al. [87] |
α5β1 ADAM17 |
Promotes | Interactions between integrin α5β1 on CRC cells and its ligand ADAM17 on exosomes facilitate CRC-derived exosome binding and uptake, promoting cancer cell invasion | Cardenes et al. [88] | |
MicroRNA-106b-5p | Promotes | MicroRNA-106b-5p promotes the polarization of M2 macrophages by inhibiting PDCD4, thereby mediating the metastasis of colorectal cancer (CRC) cells | Yang et al. [88, 89] | |
Tumor-derived exosomes | Promotes | Exosomes may facilitate colorectal cancer peritoneal metastasis progression by modulating immune responses, including increased macrophage numbers and enhanced natural killer cell activation | Tokuda et al. [90] | |
Tumor-derived exosomes | Promotes | Exosomes may undergo alterations during the peritoneal metastasis process, thereby influencing the tumor microenvironment and interactions | Vallejos et al. [91] | |
IL-4, IL-10, TGF-β, M-CSF, andprostaglandin E2 | Promotes | By promoting M2 cell polarization, tumor progression is mediated | Yin, Novak, Schreiber et al. [129–131] | |
TGF-β, TNF-β, and IGF1 | Promotes | By promoting CAFs, tumor progression is mediated | Koliaraki et al. [140] | |
FBXW7 | Inhibits | Inhibition of distant metastasis in colorectal cancer | Mlecnik, Stein, Stein et al. [165–167] | |
MUC1 | Promotes | By promoting epithelial-mesenchymal transition (EMT) while suppressing cell apoptosis | Schroeder et al. [169] | |
TIMP-2, IGF-1, and HIF-1A | Promotes | Increased expression in clones of peritoneal metastasis from colorectal cancer | Lemoine, Varghese et al. [25, 170] | |
CMS4 subtype | Promotes | Significant enrichment of CMS4 in primary tumors with peritoneal metastasis | Ubink, Laoukili et al. [171, 172] |